Results 191 to 200 of about 3,791 (213)

177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors

Expert Review of Gastroenterology and Hepatology, 2019
Satya Das, Taymeyah Al-Toubah, Jonathan Strosberg   +2 more
exaly  

Predicting 177Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

European Journal of Nuclear Medicine and Molecular Imaging
Ziqing Zeng, Zizhen Zhang, Qinghua Xie, Jinping Tao, Wenyuan Zhou, Chunhui Yuan, Zhi Yang, M. Lu, Jiangyuan Yu   +8 more
semanticscholar   +1 more source

Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

European Journal of Nuclear Medicine and Molecular Imaging, 2011
Jolanta Kunikowska, Leszek Krolicki, Alicja Hubalewska-Dydejczyk   +2 more
exaly  

Clinical utility of 177Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity

Head and Neck, 2020
Rahul V Parghane, Sanjay Talole, Devendra Chaukar   +2 more
exaly  

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children

Case Medical Research, 2019
openaire   +1 more source

Sex-dependent PRRT toxicity in patients with metastatic somatostatin receptor-avid neuroendocrine tumors treated with 177Lu-DOTATATE.

HORMONES
Shani Konyo, Reut Halperin, Nomi Bezalel Engelberg, Michal Eifer, Y. Schwarz, Liran Domachevsky, Amit Tirosh   +6 more
semanticscholar   +1 more source

Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy

Radiation and Environmental Biophysics, 2017
Mohammad Abuqbeitah, Mustafa Demir, LEBRIZ Uslu-Beşli   +2 more
exaly  

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Andrew Hendifar, James C Yao, David L Bushnell   +2 more
exaly  

Safety and outcomes of 177Lu‐DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia

Internal Medicine Journal, 2019
Enmoore Lin, Patrick Butler, Elizabeth Bailey   +2 more
exaly  

Inter-institutional variability in kidney dosimetry during 177Lu-DOTATATE therapy in Japan

Radiological Physics and Technology
Noriaki Miyaji, K. Miwa, Kosuke Yamashita, Yasuo Yamashita, N. Ukon, Matsuyoshi Ogawa, T. Konishi, Hironori Kojima, Tatsuhiko Sato, Naochika Akiya, Kaito Wachi, Arata Komatsu, Shuuhei Kimura, Tensho Yamao, Masaki Masubuchi, Yukito Maeda, Masatoshi Morimoto, Akihiro Oishi, T. Norikane, Y. Yamamoto, Yoshihiro Nishiyama, Shuhei Ohashi, Masatoshi Hotta, Takayuki Yagihashi, T. Murai, K. Nakanishi, Y. Kamitaka, R. Nishii   +27 more
semanticscholar   +1 more source